Editorial: Rising stars in clinical microbiology: 2022

Editorial: Rising stars in clinical microbiology: 2022

Bibliographic Details
Main Author:	Rafael Franco
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	SARS-CoV-2 microbiota viral infection cancer constipation rheumatoid arthritis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.1066181/full

Similar Items

Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection
by: Sofie Keijzer, et al.
Published: (2024-02-01)

Pain related viral infections: a literature review
by: I. Putu Eka Widyadharma, et al.
Published: (2020-11-01)

COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis
by: Anca Bobircă, et al.
Published: (2022-01-01)

Editorial: Rising stars in virus and host: 2022
by: Andres López-Cortés, et al.
Published: (2022-12-01)

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
by: Guilherme Dias deMelo, et al.
Published: (2021-08-01)

COVID-19: The Immune Responses and Clinical Therapy Candidates
by: Sareh Zhand, et al.
Published: (2020-08-01)

Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months
by: Yushi Nomura, et al.
Published: (2021-12-01)

Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine
by: Yushi Nomura, et al.
Published: (2021-09-01)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2022-08-01)

Editorial: Coronavirus Evolution, Cross-Species Transmission and Recombination
by: Sunil K. Lal
Published: (2022-01-01)

BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel
by: Ariel Munitz, et al.
Published: (2021-05-01)

The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study
by: Giovanni Striani, et al.
Published: (2023-07-01)

Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved
by: Xiaorong Wang, et al.
Published: (2020-06-01)

DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection
by: Ángela del Castillo-Izquierdo, et al.
Published: (2022-11-01)

Erythema annulare centrifugum in the setting of COVID‐19 infection: A case report and literature review
by: Misako Fujisaki, et al.
Published: (2023-04-01)

Differences in inflammatory markers between coronavirus disease 2019 and sepsis in hospitalised patients
by: Nery E. Linarez Ochoa, et al.
Published: (2022-05-01)

Editorial: Impact and consequences of COVID-19 on the musculoskeletal system
by: Eric Toussirot, et al.
Published: (2023-09-01)

Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review
by: David Hettle, et al.
Published: (2022-11-01)

Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
by: Andrea Picchianti-Diamanti, et al.
Published: (2023-11-01)

SARS-CoV-2 induces “cytokine storm” hyperinflammatory responses in RA patients through pyroptosis
by: Qingcong Zheng, et al.
Published: (2022-12-01)

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases
by: Nastya Kharlamova, et al.
Published: (2021-05-01)

SARS-COV-2 GENOMIC SURVEILLANCE IN BULGARIA INDICATES DIVERSE DYNAMICS DRIVEN BY MULTIPLE INTRODUCTIONS OF DIFFERENT VIRAL VARIANTS IN 2022
by: Ivaylo Alexiev, et al.
Published: (2023-08-01)

SARS-like Coronaviruses in Horseshoe Bats (<i>Rhinolophus</i> spp.) in Russia, 2020
by: Sergey Alkhovsky, et al.
Published: (2022-01-01)

Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2
by: Sounik Manna, et al.
Published: (2020-10-01)

An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value
by: Sonnleitner Sissy Therese, et al.
Published: (2021-04-01)

Editorial: Human coronavirus research: 20 years since the SARS-CoV outbreak
by: Burtram C. Fielding
Published: (2022-09-01)

The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis
by: Danielle Soares de Oliveira Daian e Silva, et al.
Published: (2021-09-01)

Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020–2022 Survey of the Pediatric Rheumatology Association of Japan
by: Hiroyuki Wakiguchi, et al.
Published: (2023-05-01)

Respiratory viral infections and the risk of rheumatoid arthritis
by: Young Bin Joo, et al.
Published: (2019-08-01)

Associations of <i>HLA</i> Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2
by: Takashi Higuchi, et al.
Published: (2023-02-01)

Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period
by: Sukbin Jang, et al.
Published: (2021-01-01)

Air Curtains Equipped With Hydroalcoholic Aerosol Sprayers for Massive COVID-19 Disinfection
by: Judit Raventós, et al.
Published: (2021-01-01)

Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease
by: Emmanuel Israel Edache, et al.
Published: (2023-09-01)

Pharmacological Efficacy of Probiotics in Respiratory Viral Infections: A Comprehensive Review
by: Shadma Wahab, et al.
Published: (2022-08-01)

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
by: Yassmin Moatasim, et al.
Published: (2023-11-01)

Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination
by: Ryousuke Koike, et al.
Published: (2022-03-01)

A 5-Lipoxygenase Inhibitor, Zileuton, Modulates Host Immune Responses and Improves Lung Function in a Model of Severe Acute Respiratory Syndrome (SARS) Induced by <i>Betacoronavirus</i>
by: Rafaela das Dores Pereira, et al.
Published: (2023-10-01)

Aptamer Applications in Emerging Viral Diseases
by: Arne Krüger, et al.
Published: (2021-06-01)

Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives
by: Kavita Narang, et al.
Published: (2021-03-01)

Host mitochondria: more than an organelle in SARS-CoV-2 infection
by: Shahrzad Shoraka, et al.
Published: (2023-08-01)